Bluejay Investor Presentation Deck
Symphony Product Pipeline Targets Multi-Billion Dollar Markets *
Plan to expand the testing menu to include other well-validated critical care biomarkers
●●●
Product Pipeline
Commercial Rights
TM
Symphony ™M IL-6 Test
To determine patient acuity
for sepsis triage/monitoring
Bluejay Diagnostics
Symphony TM hs TNT/I
To determine patient acuity
with chest pain
Bluejay Diagnostics and
Toray Industries
TM
Symphony ™M NT-proBNP
To determine patient acuity
with chest pain
Bluejay Diagnostics and
Toray Industries
bluejay
DIAGNOSTICS
Research
*Source: Bluejay Diagnostics market research
>>
>»>
Development
Clinical Testing
>>
New Tests Will Follow the IL-6 Development Pathway
Regulatory
Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | September 2022 7View entire presentation